Pay in 4 interest-free payments of $5.14 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
A 24-week clinical trial published in Obesity Research (2011) tested AOD-9604 against placebo for fat reduction and found no statistically significant difference between groups a result that has kept the compound classified primarily as a research-stage peptide rather than one with an established, reproducible metabolic effect
Retrieved June 10, 2025, from Drugs..com
- Energy/Spectroscopy Range: 30 to 662 keV (optimized for common medical gamma emitters like Tc-99m at 140 keV, I-131, Lu-177 at ~208 keV, etc.)
No Phase 1 or Phase 2 trial has been conducted for PDA as a distinct compound
US$ 29.45
US$ 27.84
US$ 25.75
,aspect=ignore)
US$ 22.25
US$ 24.13
US$ 21.66
US$ 27.36
US$ 28.98
US$ 22.45
